Patents by Inventor John Briston

John Briston has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250134856
    Abstract: The present disclosure relates to 3,4-methylenedioxymethamphetamine (MDMA) or a pharmaceutically acceptable salt and/or solvate thereof, pharmaceutical compositions and dosage forms containing these particles, and methods of using pharmaceutical compositions and dosage forms containing these particles to treat subjects suffering from disorders of the central nervous system.
    Type: Application
    Filed: December 30, 2024
    Publication date: May 1, 2025
    Inventors: Jay Nair, Berra Yazar-Klosinski, Julian Northen, Arul Balasundaram, Linda Hakes, John Briston
  • Publication number: 20250134855
    Abstract: The present disclosure relates to 3,4-methylenedioxymethamphetamine (MDMA) or a pharmaceutically acceptable salt and/or solvate thereof, pharmaceutical compositions and dosage forms containing these particles, and methods of using pharmaceutical compositions and dosage forms containing these particles to treat subjects suffering from disorders of the central nervous system.
    Type: Application
    Filed: December 30, 2024
    Publication date: May 1, 2025
    Inventors: Jay Nair, Berra Yazar-Klosinski, Julian Northen, Arul Balasundaram, Linda Hakes, John Briston
  • Publication number: 20250127756
    Abstract: The present disclosure relates to 3,4-methylenedioxymethamphetamine (MDMA) or a pharmaceutically acceptable salt and/or solvate thereof, pharmaceutical compositions and dosage forms containing these particles, and methods of using pharmaceutical compositions and dosage forms containing these particles to treat subjects suffering from disorders of the central nervous system.
    Type: Application
    Filed: December 30, 2024
    Publication date: April 24, 2025
    Inventors: Jay Nair, Berra Yazar-Klosinski, Julian Northen, Arul Balasundaram, Linda Hakes, John Briston
  • Publication number: 20250127757
    Abstract: The present disclosure relates to 3,4-methylenedioxymethamphetamine (MDMA) or a pharmaceutically acceptable salt and/or solvate thereof, pharmaceutical compositions and dosage forms containing these particles, and methods of using pharmaceutical compositions and dosage forms containing these particles to treat subjects suffering from disorders of the central nervous system.
    Type: Application
    Filed: December 30, 2024
    Publication date: April 24, 2025
    Inventors: Jay Nair, Berra Yazar-Klosinski, Julian Northen, Arul Balasundaram, Linda Hakes, John Briston
  • Publication number: 20240285577
    Abstract: The present disclosure relates to 3,4-methylenedioxymethamphetamine (MDMA) or a pharmaceutically acceptable salt and/or solvate thereof, pharmaceutical compositions and dosage forms containing these particles, and methods of using pharmaceutical compositions and dosage forms containing these particles to treat subjects suffering from disorders of the central nervous system.
    Type: Application
    Filed: March 20, 2024
    Publication date: August 29, 2024
    Inventors: Jay Nair, Berra Yazar-Klosinski, Julian Northen, Arul Balasundaram, Linda Hakes, John Briston